Early outcomes in kidney transplant recipients with systemic lupus erythematosus View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-01-02

AUTHORS

Jorge Mario López-Morales, Lauro Quintanilla-González, Juan Carlos Ramírez-Sandoval, Andrea Hinojosa-Azaola

ABSTRACT

Kidney transplant (KT) is the best treatment for patients who progress to end-stage renal disease. Short-term outcomes in patients with systemic lupus erythematosus (SLE) following KT are not well known. To describe the postoperative outcomes and complications in SLE patients undergoing KT, we conducted a case–control study from 2010 to 2015 including SLE recipients compared to non-SLE controls matched by age and sex. Demographics, comorbidities, donor characteristics, and preoperative tests were retrieved. Main outcomes were 30-day postoperative allograft function, development of infectious or non-infectious complications, and mortality. 68 patients (34 SLE, 34 non-SLE) were included. SLE recipients had median disease duration of 9 years; SLEDAI-2K of 2, and SLICC/ACR damage index of 3; 16 (47%) were taking prednisone (median dose 5 mg daily) before KT. SLE recipients had a lower frequency of diabetes (0 vs. 27%, p = 0.002). No differences were found in the development of any complication (50% SLE vs. 47% non-SLE, p = 1.00); infectious (44% vs. 41%, p = 1.00), or non-infectious (15% vs. 21%, p = 1.00). There were no deaths in either group, and none of the SLE recipients presented lupus disease activity 30 days after the KT. Allograft function determined by serum creatinine, estimated glomerular filtration rate, delayed graft function, and allograft loss was similar in both groups (p > 0.05). There were no differences between SLE recipients with and without complications. Early postoperative outcomes in SLE patients who undergo KT, including allograft function, development of infectious, non-infectious complications, and mortality, are similar to patients without SLE. More... »

PAGES

479-487

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00296-018-4234-7

DOI

http://dx.doi.org/10.1007/s00296-018-4234-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111051962

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30600343


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatinine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Delayed Graft Function", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Failure, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lupus Erythematosus, Systemic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lupus Nephritis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mortality", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Complications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga No. 15, Col. Secci\u00f3n XVI, Tlalpan, CP 14000, Mexico City, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.416850.e", 
          "name": [
            "Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga No. 15, Col. Secci\u00f3n XVI, Tlalpan, CP 14000, Mexico City, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00f3pez-Morales", 
        "givenName": "Jorge Mario", 
        "id": "sg:person.013743663337.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013743663337.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga No. 15, Col. Secci\u00f3n XVI, Tlalpan, CP 14000, Mexico City, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.416850.e", 
          "name": [
            "Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga No. 15, Col. Secci\u00f3n XVI, Tlalpan, CP 14000, Mexico City, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quintanilla-Gonz\u00e1lez", 
        "givenName": "Lauro", 
        "id": "sg:person.016602364305.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016602364305.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.416850.e", 
          "name": [
            "Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ram\u00edrez-Sandoval", 
        "givenName": "Juan Carlos", 
        "id": "sg:person.0720323276.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720323276.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga No. 15, Col. Secci\u00f3n XVI, Tlalpan, CP 14000, Mexico City, Mexico", 
          "id": "http://www.grid.ac/institutes/grid.416850.e", 
          "name": [
            "Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Vasco de Quiroga No. 15, Col. Secci\u00f3n XVI, Tlalpan, CP 14000, Mexico City, Mexico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hinojosa-Azaola", 
        "givenName": "Andrea", 
        "id": "sg:person.0651413346.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651413346.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10067-011-1931-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053365835", 
          "https://doi.org/10.1007/s10067-011-1931-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01-02", 
    "datePublishedReg": "2019-01-02", 
    "description": "Kidney transplant (KT) is the best treatment for patients who progress to end-stage renal disease. Short-term outcomes in patients with systemic lupus erythematosus (SLE) following KT are not well known. To describe the postoperative outcomes and complications in SLE patients undergoing KT, we conducted a case\u2013control study from 2010 to 2015 including SLE recipients compared to non-SLE controls matched by age and sex. Demographics, comorbidities, donor characteristics, and preoperative tests were retrieved. Main outcomes were 30-day postoperative allograft function, development of infectious or non-infectious complications, and mortality. 68 patients (34 SLE, 34 non-SLE) were included. SLE recipients had median disease duration of 9\u00a0years; SLEDAI-2K of 2, and SLICC/ACR damage index of 3; 16 (47%) were taking prednisone (median dose 5\u00a0mg daily) before KT. SLE recipients had a lower frequency of diabetes (0 vs. 27%, p\u2009=\u20090.002). No differences were found in the development of any complication (50% SLE vs. 47% non-SLE, p\u2009=\u20091.00); infectious (44% vs. 41%, p\u2009=\u20091.00), or non-infectious (15% vs. 21%, p\u2009=\u20091.00). There were no deaths in either group, and none of the SLE recipients presented lupus disease activity 30\u00a0days after the KT. Allograft function determined by serum creatinine, estimated glomerular filtration rate, delayed graft function, and allograft loss was similar in both groups (p\u2009>\u20090.05). There were no differences between SLE recipients with and without complications. Early postoperative outcomes in SLE patients who undergo KT, including allograft function, development of infectious, non-infectious complications, and mortality, are similar to patients without SLE.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00296-018-4234-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093123", 
        "issn": [
          "0172-8172", 
          "1437-160X"
        ], 
        "name": "Rheumatology International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "keywords": [
      "systemic lupus erythematosus", 
      "non-infectious complications", 
      "kidney transplant", 
      "allograft function", 
      "SLE patients", 
      "postoperative outcomes", 
      "lupus erythematosus", 
      "SLICC/ACR Damage Index", 
      "end-stage renal disease", 
      "non-SLE controls", 
      "postoperative allograft function", 
      "median disease duration", 
      "SLEDAI-2K", 
      "early postoperative outcomes", 
      "kidney transplant recipients", 
      "glomerular filtration rate", 
      "short-term outcomes", 
      "case-control study", 
      "allograft loss", 
      "graft function", 
      "transplant recipients", 
      "disease duration", 
      "serum creatinine", 
      "renal disease", 
      "preoperative tests", 
      "early outcomes", 
      "filtration rate", 
      "MAIN OUTCOME", 
      "complications", 
      "patients", 
      "donor characteristics", 
      "recipients", 
      "best treatment", 
      "outcomes", 
      "erythematosus", 
      "mortality", 
      "activity 30", 
      "prednisone", 
      "comorbidities", 
      "diabetes", 
      "creatinine", 
      "group", 
      "transplant", 
      "disease", 
      "demographics", 
      "death", 
      "age", 
      "sex", 
      "treatment", 
      "differences", 
      "duration", 
      "damage index", 
      "days", 
      "low frequency", 
      "function", 
      "years", 
      "development", 
      "index", 
      "control", 
      "study", 
      "rate", 
      "test", 
      "loss", 
      "frequency", 
      "characteristics", 
      "SLE recipients", 
      "ACR damage index", 
      "lupus disease activity 30", 
      "disease activity 30"
    ], 
    "name": "Early outcomes in kidney transplant recipients with systemic lupus erythematosus", 
    "pagination": "479-487", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111051962"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00296-018-4234-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30600343"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00296-018-4234-7", 
      "https://app.dimensions.ai/details/publication/pub.1111051962"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_820.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00296-018-4234-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4234-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4234-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4234-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00296-018-4234-7'


 

This table displays all metadata directly associated to this object as RDF triples.

218 TRIPLES      22 PREDICATES      111 URIs      102 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00296-018-4234-7 schema:about N2ed80a6a7a5349f0af7d16ed9bfa49a2
2 N3a9dbe6ee3dc4247b99bd9bfb23dc811
3 N4435d509f0f04ca1b94fdf1b35079a0f
4 N4843c40561d24e478eb9238c37941890
5 N5c03b835e4aa4e068874c5b9b60dd860
6 N5ee4f533ef2a4eeeb5e579f408ec7145
7 N71a0bf25855443b99d0c4ac87f75a2d3
8 N7a697028826d49438813a65a296e605f
9 N9273e9064df741aa844e7e031d3f2fab
10 Nbb8a3306878441ff89aa9efac70bd332
11 Nc78502a5cdbc4269b94ba0057b237c04
12 Ncdac8885f2ce40b493b0e0cab046effe
13 Nd1beeb222a6e4ba2a67b1ae17826261b
14 Ned51da2728744de0b7fdf55a42347520
15 Nf71a52f13e144ed2bdc9f18686b7cb75
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N238cd96b55774f8cabb96eb562865231
19 schema:citation sg:pub.10.1007/s10067-011-1931-y
20 schema:datePublished 2019-01-02
21 schema:datePublishedReg 2019-01-02
22 schema:description Kidney transplant (KT) is the best treatment for patients who progress to end-stage renal disease. Short-term outcomes in patients with systemic lupus erythematosus (SLE) following KT are not well known. To describe the postoperative outcomes and complications in SLE patients undergoing KT, we conducted a case–control study from 2010 to 2015 including SLE recipients compared to non-SLE controls matched by age and sex. Demographics, comorbidities, donor characteristics, and preoperative tests were retrieved. Main outcomes were 30-day postoperative allograft function, development of infectious or non-infectious complications, and mortality. 68 patients (34 SLE, 34 non-SLE) were included. SLE recipients had median disease duration of 9 years; SLEDAI-2K of 2, and SLICC/ACR damage index of 3; 16 (47%) were taking prednisone (median dose 5 mg daily) before KT. SLE recipients had a lower frequency of diabetes (0 vs. 27%, p = 0.002). No differences were found in the development of any complication (50% SLE vs. 47% non-SLE, p = 1.00); infectious (44% vs. 41%, p = 1.00), or non-infectious (15% vs. 21%, p = 1.00). There were no deaths in either group, and none of the SLE recipients presented lupus disease activity 30 days after the KT. Allograft function determined by serum creatinine, estimated glomerular filtration rate, delayed graft function, and allograft loss was similar in both groups (p > 0.05). There were no differences between SLE recipients with and without complications. Early postoperative outcomes in SLE patients who undergo KT, including allograft function, development of infectious, non-infectious complications, and mortality, are similar to patients without SLE.
23 schema:genre article
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf N5aa8fabbab4e40af87ceb0ea7946dc2f
27 Ncc0d19e287de4818842b8cec87aa9f6f
28 sg:journal.1093123
29 schema:keywords ACR damage index
30 MAIN OUTCOME
31 SLE patients
32 SLE recipients
33 SLEDAI-2K
34 SLICC/ACR Damage Index
35 activity 30
36 age
37 allograft function
38 allograft loss
39 best treatment
40 case-control study
41 characteristics
42 comorbidities
43 complications
44 control
45 creatinine
46 damage index
47 days
48 death
49 demographics
50 development
51 diabetes
52 differences
53 disease
54 disease activity 30
55 disease duration
56 donor characteristics
57 duration
58 early outcomes
59 early postoperative outcomes
60 end-stage renal disease
61 erythematosus
62 filtration rate
63 frequency
64 function
65 glomerular filtration rate
66 graft function
67 group
68 index
69 kidney transplant
70 kidney transplant recipients
71 loss
72 low frequency
73 lupus disease activity 30
74 lupus erythematosus
75 median disease duration
76 mortality
77 non-SLE controls
78 non-infectious complications
79 outcomes
80 patients
81 postoperative allograft function
82 postoperative outcomes
83 prednisone
84 preoperative tests
85 rate
86 recipients
87 renal disease
88 serum creatinine
89 sex
90 short-term outcomes
91 study
92 systemic lupus erythematosus
93 test
94 transplant
95 transplant recipients
96 treatment
97 years
98 schema:name Early outcomes in kidney transplant recipients with systemic lupus erythematosus
99 schema:pagination 479-487
100 schema:productId N54ab018fac2b41a1a2148f72ee24065d
101 Na7c75acec9c946b9a6fe077d1bc36de5
102 Nc26416a01b1040c5bf8db6b71026f3c1
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111051962
104 https://doi.org/10.1007/s00296-018-4234-7
105 schema:sdDatePublished 2021-12-01T19:45
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher Nabf3547e25aa4ebe8080557b5cbef17f
108 schema:url https://doi.org/10.1007/s00296-018-4234-7
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N0b5e5a25088147d392287e13eefa4072 rdf:first sg:person.0651413346.14
113 rdf:rest rdf:nil
114 N238cd96b55774f8cabb96eb562865231 rdf:first sg:person.013743663337.74
115 rdf:rest N710eb2c9f3214349a76058d3403ef735
116 N2ed80a6a7a5349f0af7d16ed9bfa49a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Delayed Graft Function
118 rdf:type schema:DefinedTerm
119 N3a9dbe6ee3dc4247b99bd9bfb23dc811 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Postoperative Complications
121 rdf:type schema:DefinedTerm
122 N4435d509f0f04ca1b94fdf1b35079a0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Kidney Transplantation
124 rdf:type schema:DefinedTerm
125 N4843c40561d24e478eb9238c37941890 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Lupus Nephritis
127 rdf:type schema:DefinedTerm
128 N54ab018fac2b41a1a2148f72ee24065d schema:name pubmed_id
129 schema:value 30600343
130 rdf:type schema:PropertyValue
131 N5aa8fabbab4e40af87ceb0ea7946dc2f schema:issueNumber 3
132 rdf:type schema:PublicationIssue
133 N5c03b835e4aa4e068874c5b9b60dd860 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Middle Aged
135 rdf:type schema:DefinedTerm
136 N5ee4f533ef2a4eeeb5e579f408ec7145 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Lupus Erythematosus, Systemic
138 rdf:type schema:DefinedTerm
139 N710eb2c9f3214349a76058d3403ef735 rdf:first sg:person.016602364305.94
140 rdf:rest Nc37691a2dc3d48c58c9f278381055a33
141 N71a0bf25855443b99d0c4ac87f75a2d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Male
143 rdf:type schema:DefinedTerm
144 N7a697028826d49438813a65a296e605f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Adult
146 rdf:type schema:DefinedTerm
147 N9273e9064df741aa844e7e031d3f2fab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Female
149 rdf:type schema:DefinedTerm
150 Na7c75acec9c946b9a6fe077d1bc36de5 schema:name doi
151 schema:value 10.1007/s00296-018-4234-7
152 rdf:type schema:PropertyValue
153 Nabf3547e25aa4ebe8080557b5cbef17f schema:name Springer Nature - SN SciGraph project
154 rdf:type schema:Organization
155 Nbb8a3306878441ff89aa9efac70bd332 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Humans
157 rdf:type schema:DefinedTerm
158 Nc26416a01b1040c5bf8db6b71026f3c1 schema:name dimensions_id
159 schema:value pub.1111051962
160 rdf:type schema:PropertyValue
161 Nc37691a2dc3d48c58c9f278381055a33 rdf:first sg:person.0720323276.91
162 rdf:rest N0b5e5a25088147d392287e13eefa4072
163 Nc78502a5cdbc4269b94ba0057b237c04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Kidney Failure, Chronic
165 rdf:type schema:DefinedTerm
166 Ncc0d19e287de4818842b8cec87aa9f6f schema:volumeNumber 39
167 rdf:type schema:PublicationVolume
168 Ncdac8885f2ce40b493b0e0cab046effe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Recurrence
170 rdf:type schema:DefinedTerm
171 Nd1beeb222a6e4ba2a67b1ae17826261b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Mortality
173 rdf:type schema:DefinedTerm
174 Ned51da2728744de0b7fdf55a42347520 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Creatinine
176 rdf:type schema:DefinedTerm
177 Nf71a52f13e144ed2bdc9f18686b7cb75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Treatment Outcome
179 rdf:type schema:DefinedTerm
180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
181 schema:name Medical and Health Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
184 schema:name Clinical Sciences
185 rdf:type schema:DefinedTerm
186 sg:journal.1093123 schema:issn 0172-8172
187 1437-160X
188 schema:name Rheumatology International
189 schema:publisher Springer Nature
190 rdf:type schema:Periodical
191 sg:person.013743663337.74 schema:affiliation grid-institutes:grid.416850.e
192 schema:familyName López-Morales
193 schema:givenName Jorge Mario
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013743663337.74
195 rdf:type schema:Person
196 sg:person.016602364305.94 schema:affiliation grid-institutes:grid.416850.e
197 schema:familyName Quintanilla-González
198 schema:givenName Lauro
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016602364305.94
200 rdf:type schema:Person
201 sg:person.0651413346.14 schema:affiliation grid-institutes:grid.416850.e
202 schema:familyName Hinojosa-Azaola
203 schema:givenName Andrea
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651413346.14
205 rdf:type schema:Person
206 sg:person.0720323276.91 schema:affiliation grid-institutes:grid.416850.e
207 schema:familyName Ramírez-Sandoval
208 schema:givenName Juan Carlos
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720323276.91
210 rdf:type schema:Person
211 sg:pub.10.1007/s10067-011-1931-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1053365835
212 https://doi.org/10.1007/s10067-011-1931-y
213 rdf:type schema:CreativeWork
214 grid-institutes:grid.416850.e schema:alternateName Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, CP 14000, Mexico City, Mexico
215 Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
216 schema:name Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, CP 14000, Mexico City, Mexico
217 Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
218 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...